髂胫束自体移植髋臼盂唇重建:至少10年随访的结局与生存率
回顾性分析91髋(89例)2006至2008年行关节镜下髂胫束自体移植盂唇重建的患者,至少10年随访时总体生存率(以翻修髋关节镜或全髋关节置换为终点)5年为70%、10年为61%;未再次手术者HOS-ADL从术前69改善至90,患者满意度中位数10分。
要点
- 至少10年随访中,9%的髋行翻修关节镜,27%行全髋关节置换。
- 以翻修髋关节镜或全髋关节置换为终点,10年生存率为61%。
- 关节间隙大于2 mm者10年生存率为90%。
核心结论
- 关节镜下髂胫束自体移植盂唇重建后,9%的髋行翻修关节镜,27%行全髋关节置换。
- 10年时以翻修髋关节镜或全髋关节置换为终点的生存率为61%;对于关节间隙大于2 mm者(当前盂唇重建适应证),10年生存率为90%。
- 未需翻修或全髋关节置换者报告了优良的患者报告结局和患者满意度。
- 通过适当的患者选择和预防术后粘连,盂唇重建可产生优良结局和高患者满意度,并在至少10年随访中维持。
研究设计与样本
- 回顾性评估前瞻性收集的单术者数据库,纳入2006年至2008年间接受关节镜下髂胫束自体移植盂唇重建的91髋(89例患者)。
- 主要患者报告结局为髋关节结局评分(HOS)日常生活活动(ADL)分量表。
- 同时收集改良Harris髋关节评分(mHHS)、HOS运动分量表、西安大略和麦克马斯特大学骨关节炎指数(WOMAC)评分及患者满意度(1至10分)。
- 在至少10年随访时评估生存率分析曲线。
- 证据等级:治疗性IV级。
主要发现
- 至少10年随访时评估了82髋。
- 以翻修髋关节镜或全髋关节置换为终点的总体生存率5年为70%、10年为61%,平均生存时间为9年(95%置信区间=7.6至10年)。
- 未行后续手术的患者中,mHHS平均从术前60增加至10年随访时82(p=0.001)。
- 未行后续手术的患者中,HOS-ADL从69改善至90(p=0.004),HOS-运动从43改善至76(p=0.001),患者满意度中位数为10分(满分10分)。
- 80%的患者达到HOS-ADL的最小临床重要差异(MCID),87%获得患者可接受症状状态(PASS)。
关键数值与推荐
- 以翻修髋关节镜或全髋关节置换为终点,5年生存率为70%,10年生存率为61%。
- 对于关节间隙大于2 mm者(当前盂唇重建适应证),10年生存率为90%。
- 未行后续手术者mHHS从术前60增至10年随访82(p=0.001),HOS-ADL从69增至90(p=0.004),HOS-运动从43增至76(p=0.001)。
- 80%的患者达到HOS-ADL的MCID,87%获得PASS。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Labral reconstruction has been shown to result in improved patient-reported outcomes (PROs) at mid-term follow-up in patients with a deficient labrum. The purpose of this study was to determine survivorship and PROs at a minimum 10-year follow-up. METHODS: A retrospective evaluation of a prospectively collected single-surgeon database included 91 hips (89 patients) that underwent arthroscopic labral reconstruction with iliotibial band autograft between 2006 and 2008. The primary PRO was the Hip Outcome Score (HOS)-activities of daily living (ADL). The modified Harris hip score (mHHS), HOS-sports, Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) score, and patient satisfaction (on a scale of 1 to 10) were also collected at a 10-year minimum follow-up. Survivorship analysis curves were evaluated. RESULTS: Eighty-two hips were evaluated at a 10-year minimum follow-up. Overall survivorship, with revision hip arthroscopy or total hip arthroplasty (THA) as the end point, was 70% at 5 years and 61% at 10 years, and the mean survival time was 9 years (95% confidence interval = 7.6 to 10 years). For the patients who did not undergo subsequent surgery, on average the mHHS increased from 60 preoperatively to 82 at the 10-year follow-up (p = 0.001), the HOS-ADL improved from 69 to 90 (p = 0.004), the HOS-sports improved from 43 to 76 (p = 0.001), and the median patient satisfaction was 10 of 10. Eighty percent of the patients achieved the minimal clinically important difference (MCID) in the HOS-ADL, and 87% obtained a patient acceptable symptom state (PASS). CONCLUSIONS: Following arthroscopic labral reconstruction with iliotibial band autograft, 9% of the hips underwent revision arthroscopy and 27% underwent THA. At 10 years, the survival rate, with revision hip arthroscopy or THA as the end point, was 61%; however, for those with >2 mm of joint space, the current indication for labral reconstruction, the 10-year survival rate was 90%. Excellent PROs and patient satisfaction were reported by those who did not require revision or THA. With appropriate patient selection and prevention of postoperative adhesions, labral reconstruction results in excellent outcomes and high patient satisfaction that is sustained at a minimum 10-year follow-up. LEVEL OF EVIDENCE: Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.
引用
- Philippon MJ, Arner JW, Crawford MD, et al. Acetabular Labral Reconstruction with Iliotibial Band Autograft: Outcome and Survivorship at a Minimum 10-Year Follow-up. J Bone Joint Surg Am. 2020. PMID: 32675477. doi:10.2106/JBJS.19.01499
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。